| 000 | 01911 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250513154710.0 | ||
| 264 | 0 | _c19990209 | |
| 008 | 199902s 0 0 eng d | ||
| 022 | _a1078-0432 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFleming, R A | |
| 245 | 0 | 0 |
_aPhase I study of N-(phosphonacetyl)-L-aspartate with fluorouracil and with or without dipyridamole in patients with advanced cancer. _h[electronic resource] |
| 260 |
_bClinical cancer research : an official journal of the American Association for Cancer Research _cJul 1996 |
||
| 300 |
_a1107-14 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 |
_aAspartate Carbamoyltransferase _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aAspartic Acid _xadministration & dosage |
| 650 | 0 | 4 |
_aDipyridamole _xadministration & dosage |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluorouracil _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukocytes _xenzymology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aPhosphonoacetic Acid _xadministration & dosage |
| 650 | 0 | 4 |
_aUridine Triphosphate _xmetabolism |
| 700 | 1 | _aCapizzi, R L | |
| 700 | 1 | _aMuss, H B | |
| 700 | 1 | _aSmith, S | |
| 700 | 1 | _aFernandes, D J | |
| 700 | 1 | _aHomesley, H | |
| 700 | 1 | _aLoggie, B W | |
| 700 | 1 | _aCase, L | |
| 700 | 1 | _aMorris, R | |
| 700 | 1 | _aRussell, G B | |
| 700 | 1 | _aRichards, F | |
| 773 | 0 |
_tClinical cancer research : an official journal of the American Association for Cancer Research _gvol. 2 _gno. 7 _gp. 1107-14 |
|
| 999 |
_c9780494 _d9780494 |
||